Characterizing Myositis With 68Ga-FAPI PET/CT
Myositis, Idiopathic Inflammatory Myopathies
About this trial
This is an interventional diagnostic trial for Myositis
Eligibility Criteria
Inclusion Criteria: A diagnosis of myositis according to American College of Rheumatology/European League Against Rheumatism 2017 (ACR/EULAR 2017) criteria Adult men or women 18 and ≤ 75 years of age at the time of signing the informed consent (ICF). Participants who were able to provide informed consent (signed by participant or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee. 68Ga-FAPI and 18F-FDG PET/CT were performed within two weeks. Exclusion Criteria: Pregnancy; Breastfeeding; known allergy against FAPI; any medical condition that in the opinion of the investigator may significantly interfere with study compliance.
Sites / Locations
- The first affiliated hospital of Xiamen UniversityRecruiting
Arms of the Study
Arm 1
Experimental
68Ga-FAPI
Inject 68Ga-FAPI and then perform PET/CT scan